Form 8-K - Current report:
SEC Accession No. 0000320017-16-000144
Filing Date
2016-08-09
Accepted
2016-08-09 16:18:27
Documents
4
Period of Report
2016-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K 08.09.16 a8-k8916.htm 8-K 29513
2 EXHIBIT 10.1 DWL AGREEMENT exhibit101dwlletteragreeme.htm EX-10.1 12878
3 EXHIBIT 99.1 EARNINGS PR exhibit991pr8916.htm EX-99.1 114271
4 caladriuslogoa06.jpg GRAPHIC 333151
  Complete submission text file 0000320017-16-000144.txt   616992
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 161818173
SIC: 8090 Services-Misc Health & Allied Services, NEC